Unnamed: 0,title,date,stock,sentiment
668093.0,Inogen Reports CEO Scott Wilkinson To Retire,2020-06-09 17:16:00-04:00,INGN,neutral
668094.0,31 Stocks Moving in Wednesday's Pre-Market Session,2020-06-03 07:10:00-04:00,INGN,neutral
668095.0,"SVB Leerink Maintains Market Perform on Inogen, Lowers Price Target to $42",2020-06-01 05:11:00-04:00,INGN,negative
668096.0,66 Biggest Movers From Yesterday,2020-05-07 05:52:00-04:00,INGN,neutral
668097.0,Mid-Afternoon Market Update: NASDAQ Jumps Over 100 Points; Nautilus Shares Plummet,2020-05-06 14:35:00-04:00,INGN,positive
668098.0,58 Stocks Moving In Wednesday's Mid-Day Session,2020-05-06 13:19:00-04:00,INGN,neutral
668099.0,Mid-Day Market Update: Crude Oil Down 6%; Cars.com Shares Jump On Upbeat Q1 Results,2020-05-06 12:48:00-04:00,INGN,negative
668100.0,"SVB Leerink Maintains Market Perform on Inogen, Lowers Price Target of $56",2020-05-06 12:25:00-04:00,INGN,negative
668101.0,Mid-Morning Market Update: Markets Mixed; General Motors Beats Q1 Views,2020-05-06 10:22:00-04:00,INGN,neutral
668102.0,"Needham Maintains Buy on Inogen, Lowers Price Target to $75",2020-05-06 06:38:00-04:00,INGN,negative
668103.0,Inogen Withdraws FY20 Guidance,2020-05-05 16:21:00-04:00,INGN,neutral
668104.0,"Inogen Q1 EPS $(0.070) Beats $(0.100) Estimate, Sales $88.500M Beat $82.330M Estimate",2020-05-05 16:21:00-04:00,INGN,neutral
668105.0,111 Biggest Movers From Yesterday,2020-03-24 04:18:00-04:00,INGN,neutral
668106.0,71 Stocks Moving In Monday's Mid-Day Session,2020-03-23 12:31:00-04:00,INGN,neutral
668107.0,95 Biggest Movers From Yesterday,2020-02-27 05:18:00-05:00,INGN,neutral
668108.0,75 Stocks Moving In Wednesday's Mid-Day Session,2020-02-26 12:18:00-05:00,INGN,neutral
668109.0,Stocks That Hit 52-Week Lows On Wednesday,2020-02-26 11:14:00-05:00,INGN,negative
668110.0,"JP Morgan Maintains Underweight on Inogen, Lowers Price Target to $45",2020-02-26 08:03:00-05:00,INGN,positive
668111.0,Inogen Reaffirms FY20 Sales Guidance $385M-$400M,2020-02-25 16:21:00-05:00,INGN,neutral
668112.0,"Inogen Q4 GAAP EPS $(0.06), Sales $78.9M Miss $86.42M Estimate",2020-02-25 16:21:00-05:00,INGN,negative
668113.0,85 Biggest Movers From Yesterday,2020-01-14 04:52:00-05:00,INGN,neutral
668114.0,41 Stocks Moving In Monday's Mid-Day Session,2020-01-13 12:21:00-05:00,INGN,neutral
668115.0,"Inogen Sees Prelim. Q4 Sales $78.4M-$79.4M vs $89.96M Est., Prelim. FY19 Sales $361.4M-$362.4M vs $372.96M Est; Sees FY20 Sales $385M-$400M vs $411.23M Est.",2020-01-13 08:27:00-05:00,INGN,neutral
668116.0,"JP Morgan Maintains Underweight on Inogen, Raises Price Target to $60",2019-12-20 09:35:00-05:00,INGN,positive
668117.0,60 Biggest Movers From Yesterday,2019-11-07 05:44:00-05:00,INGN,neutral
668118.0,62 Stocks Moving In Wednesday's Mid-Day Session,2019-11-06 13:48:00-05:00,INGN,neutral
668119.0,"Benzinga's Top Upgrades, Downgrades For November 6, 2019",2019-11-06 09:56:00-05:00,INGN,positive
668120.0,"Needham Upgrades Inogen to Buy, Announces $90 Price Target",2019-11-06 08:17:00-05:00,INGN,neutral
668121.0,28 Stocks Moving in Wednesday's Pre-Market Session,2019-11-06 07:24:00-05:00,INGN,neutral
668122.0,Inogen shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company issued FY20 sales guidance above analyst estimates.,2019-11-05 16:53:00-05:00,INGN,positive
668123.0,Inogen Sees FY19 Sales $370M-$375M Vs. $371.72M Est.; FY20 Sales $410M-$415M Vs. $407.91M Est.,2019-11-05 16:25:00-05:00,INGN,neutral
668124.0,"Inogen Q3 EPS $0.31 Beats $0.23 Estimate, Sales $91.8M Beat $91.65M Estimate",2019-11-05 16:22:00-05:00,INGN,neutral
668125.0,"Benzinga's Top Upgrades, Downgrades For August 8, 2019",2019-08-08 09:48:00-04:00,INGN,positive
668126.0,10 Biggest Price Target Changes For Thursday,2019-08-08 09:02:00-04:00,INGN,neutral
668127.0,"SVB Leerink Downgrades Inogen to Market Perform, Lowers Price Target to $47",2019-08-08 07:37:00-04:00,INGN,negative
668128.0,"Stifel Nicolaus Downgrades Inogen to Hold, Lowers Price Target to $48",2019-08-08 06:54:00-04:00,INGN,negative
668129.0,90 Biggest Movers From Yesterday,2019-08-08 05:17:00-04:00,INGN,neutral
668130.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,INGN,negative
668131.0,75 Stocks Moving In Wednesday's Mid-Day Session,2019-08-07 13:16:00-04:00,INGN,neutral
668132.0,Inogen shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results. The company also cut FY19 sales guidance.,2019-08-07 11:49:00-04:00,INGN,negative
668133.0,"Inogen Cuts FY19 Sales Guidance From $405M-$415M To $370M-$375M vs $408.9M Estimate, Adj. EBITDA From $66M-$68M to $49M-$51M",2019-08-07 08:44:00-04:00,INGN,negative
668134.0,"Inogen Q2 EPS $0.45 Misses $0.49 Estimate, Sales $101.1M Miss $106.87M Estimate",2019-08-07 08:43:00-04:00,INGN,negative
668135.0,Earnings Preview: Inogen,2019-08-06 14:28:00-04:00,INGN,neutral
668136.0,New 52-Week Lows For Monday Morning,2019-08-05 13:16:00-04:00,INGN,negative
668137.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,INGN,neutral
668138.0,"Benzinga's Top Upgrades, Downgrades For July 3, 2019",2019-07-03 10:27:00-04:00,INGN,positive
668139.0,A Peek Into The Markets: US Stock Futures Rise Ahead Of Economic Reports,2019-07-03 06:42:00-04:00,INGN,neutral
668140.0,"JP Morgan Downgrades Inogen to Underweight, Announces $72 Price Target",2019-07-03 06:28:00-04:00,INGN,positive
668141.0,Needham Downgrades Inogen to Buy,2019-06-28 08:23:00-04:00,INGN,neutral
668142.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Thur., May 9, 2019",2019-05-09 10:27:00-04:00,INGN,positive
668143.0,95 Biggest Movers From Yesterday,2019-05-09 05:01:00-04:00,INGN,neutral
668144.0,Mid-Afternoon Market Update: Dow Rises Over 100 Points; MoneyGram International Shares Slide,2019-05-08 14:42:00-04:00,INGN,positive
668145.0,Mid-Day Market Update: Inogen Drops On Earnings Miss; MACOM Shares Jump,2019-05-08 12:39:00-04:00,INGN,positive
668146.0,75 Stocks Moving In Wednesday's Mid-Day Session,2019-05-08 12:24:00-04:00,INGN,neutral
668147.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wed., May 8, 2019",2019-05-08 10:45:00-04:00,INGN,positive
668148.0,Mid-Morning Market Update: Markets Open Flat; McKesson Earnings Top Views,2019-05-08 10:15:00-04:00,INGN,positive
668149.0,"Benzinga's Top Upgrades, Downgrades For May 8, 2019",2019-05-08 09:36:00-04:00,INGN,positive
668150.0,Inogen shares are trading lower after the company reported worse-than-expected Q1 financial results and lowered its 2019 sales guidance. JP Morgan lowered its rating of the stock from Overweight to Neutral and lowered its price target from $175 to $72.,2019-05-08 09:13:00-04:00,INGN,negative
668151.0,"Stifel Nicolaus Maintains Buy on Inogen, Inc - Common Stock, Lowers Price Target to $85",2019-05-08 08:58:00-04:00,INGN,negative
668152.0,33 Stocks Moving In Wednesday's Pre-Market Session,2019-05-08 08:22:00-04:00,INGN,neutral
668153.0,"JP Morgan Downgrades Inogen, Inc - Common Stock to Neutral, Lowers Price Target to $72",2019-05-08 06:35:00-04:00,INGN,positive
668154.0,Inogen shares are trading lower after the company reported worse-than-expected Q1 EPS and sales.,2019-05-07 16:16:00-04:00,INGN,neutral
668155.0,Inogen Guides Lowers FY19 Revenue Guidance From $430M-$440M To $405M-$415M Vs. $433.73M Estimate; Reduces FY19 GAAP Net Income Guidance From $40M-$44M To $36M-$38M,2019-05-07 16:13:00-04:00,INGN,negative
668156.0,Inogen Shares To Resume Trade At 4:35 p.m. EDT,2019-05-07 16:12:00-04:00,INGN,positive
668157.0,"Inogen Q1 EPS $0.24 Misses $0.31 Estimate, Sales $90.2M Miss $91.32M Estimate",2019-05-07 16:10:00-04:00,INGN,negative
668158.0,Inogen Shares Halted News Pending,2019-05-07 16:03:00-04:00,INGN,positive
668159.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,INGN,positive
668160.0,Shares of several medical device companies are trading lower with the healthcare sector. Healthcare has seen weakness recently due to concerns over the future of the Affordable Act under Trump and healthcare policy uncertainty ahead of the 2020 election.,2019-04-17 12:45:00-04:00,INGN,negative
668161.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",2019-02-28 08:24:00-05:00,INGN,positive
668162.0,84 Biggest Movers From Yesterday,2019-02-28 05:10:00-05:00,INGN,neutral
668163.0,72 Stocks Moving In Wednesday's Mid-Day Session,2019-02-27 12:20:00-05:00,INGN,neutral
668164.0,Mid-Morning Market Update: Markets Open Lower; Lowe's Profit Tops Estimates,2019-02-27 10:22:00-05:00,INGN,positive
668165.0,Inogen shares are trading lower despite the company reporting better than expected Q4 EPS and revenue results. Analysts at KeyBanc credit the decline to investors expecting larger earnings beats and increasing marketing spend.,2019-02-27 09:42:00-05:00,INGN,positive
668166.0,35 Stocks Moving In Wednesday's Pre-Market Session,2019-02-27 08:25:00-05:00,INGN,neutral
668167.0,"The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings",2019-02-27 08:13:00-05:00,INGN,neutral
668168.0,Inogen Reaffirms FY19 Sales Guidance $430M-$440M vs $436.4M Estimate,2019-02-26 17:24:00-05:00,INGN,neutral
668169.0,"Inogen Q4 EPS $0.44 Beats $0.25 Estimate, Sales $86.5M Beat $82.06M Estimate",2019-02-26 17:23:00-05:00,INGN,neutral
668170.0,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",2019-02-26 07:56:00-05:00,INGN,positive
668171.0,"Inogen shares are trading lower after shortseller Citron Research released a negative report on the company, citing 'elder abuse' within its sale tactics.",2019-02-12 10:33:00-05:00,INGN,negative
668172.0,'Citron exposes the deception that underpins INGN salesforce with pictures and videos.  Distribution network borders on elder abuse. The information the company and analysts don't want you to know' -Citron Research Tweets,2019-02-12 10:32:00-05:00,INGN,negative
668173.0,"Citron Out Negative On Inogen, Citing 'Elder Abuse' Within Sale Tactics; Sets $46 Price Target",2019-02-12 10:32:00-05:00,INGN,negative
668174.0,"Inogen shares are trading lower after Muddy Waters released a short report on the company, saying management 'has created an egregiously false narrative about the Total Addressable Market (""TAM"") size and growth'.",2019-02-08 10:45:00-05:00,INGN,positive
668175.0,Muddy Waters Releases Short Report On Inogen,2019-02-08 10:44:00-05:00,INGN,neutral
668176.0,"Needham Upgrades Inogen to Strong Buy, Announces $280 Price Target",2018-11-20 06:58:00-05:00,INGN,positive
668177.0,88 Biggest Movers From Yesterday,2018-11-08 04:54:00-05:00,INGN,neutral
668178.0,70 Stocks Moving In Wednesday's Mid-Day Session,2018-11-07 12:52:00-05:00,INGN,neutral
668179.0,36 Stocks Moving In Wednesday's Pre-Market Session,2018-11-07 08:11:00-05:00,INGN,neutral
668180.0,"Inogen shares are trading down 21.9% after hours; Despite strong earnings and sales guidance, the company cut its FY18 EBITDA guidance due to continued sales and marketing investment expected in Q4.",2018-11-06 17:43:00-05:00,INGN,negative
668181.0,Inogen Sees FY2019 Sales $430.0M-440.0M vs $429.49M Est,2018-11-06 16:31:00-05:00,INGN,neutral
668182.0,"Inogen Q3 EPS $0.73 Beats $0.52 Estimate, Sales $95.291M Beat $90.94M Estimate",2018-11-06 16:30:00-05:00,INGN,neutral
668183.0,"The Daily Biotech Pulse: Verastem's Chinese Duvelisib Licensing Deal, Aldeyra's Positive Dry Eye Disease Drug Trial",2018-09-26 08:25:00-04:00,INGN,positive
668184.0,UPDATE: Vanda Pharma To Replace Inogen In S&P SmallCap 600,2018-09-25 17:22:00-04:00,INGN,neutral
668185.0,UPDATE: Inogen To Replace Rollins In S&P MidCap 400,2018-09-25 17:21:00-04:00,INGN,neutral
668186.0,"S&P Dow Jones Indices Reports Rollins Will Join S&P 500, Inogen To Join S&P MidCap 400, Vanda, Garrett Motion To Join S&P SmallCap 600",2018-09-25 17:21:00-04:00,INGN,positive
668187.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,INGN,neutral
668188.0,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",2018-09-14 08:38:00-04:00,INGN,neutral
668189.0,"Stocks Which Set New 52-Week High Yesterday, September 12",2018-09-13 09:44:00-04:00,INGN,neutral
668190.0,"The Daily Biotech Pulse: Progenics Posts Mixed Trial Results, Antitrust Nod For Galapagos-MorphoSys Collaboration, New CEO For Biopharmx",2018-09-13 08:42:00-04:00,INGN,neutral
668191.0,18 Stocks Moving In Thursday's Pre-Market Session,2018-09-13 08:19:00-04:00,INGN,neutral
668192.0,"Stocks Which Set New 52-Week High Yesterday, September 11th",2018-09-12 12:17:00-04:00,INGN,neutral
668193.0,"The Daily Biotech Pulse: Foamix Jumps on Data, Positive Results for Galapagos-Gilead's Rheumatoid Arthritis Drug, Bausch Health Trims Debt",2018-09-12 08:26:00-04:00,INGN,positive
668194.0,"Stocks Which Set New 52-Week High Friday, September 7th",2018-09-10 16:36:00-04:00,INGN,neutral
668195.0,"Benzinga's Top Upgrades, Downgrades For September 10, 2018",2018-09-10 09:31:00-04:00,INGN,positive
668196.0,"Needham Downgrades Inogen to Buy, Raises Price Target to $296",2018-09-10 07:30:00-04:00,INGN,neutral
668197.0,"Stocks Which Set New 52-Week High Friday, August 31",2018-09-04 10:29:00-04:00,INGN,neutral
668198.0,"Stocks Which Set New 52-Week High Yesterday, August 30th",2018-08-31 10:11:00-04:00,INGN,neutral
668199.0,"The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage",2018-08-31 08:29:00-04:00,INGN,positive
668200.0,"Stocks Which Set New 52-Week High Yesterday, August 29th",2018-08-30 11:47:00-04:00,INGN,neutral
668201.0,"The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",2018-08-30 08:02:00-04:00,INGN,neutral
668202.0,"Stocks Which Set New 52-Week High Yesterday, August 28th",2018-08-29 11:13:00-04:00,INGN,neutral
668203.0,"The Daily Biotech Pulse: Assertio Settles With Purdue, Emergent Biosolutions In M&A Mix, Novartis Eye Care Unit Recalls Stent",2018-08-29 07:54:00-04:00,INGN,positive
668204.0,"The Daily Biotech Pulse: Regulatory Roadblock For Akcea-Ionis, Affimed's Alliance, FDA Nod For Tetraphase's Antibiotic",2018-08-28 08:13:00-04:00,INGN,neutral
668205.0,"Stocks Which Set New 52-Week High Friday, August 24th",2018-08-27 09:24:00-04:00,INGN,neutral
668206.0,"Stocks Which Set New 52-Week High Yesterday, August 23rd",2018-08-24 09:11:00-04:00,INGN,neutral
668207.0,"Stocks Which Set New 52-Week High Yesterday, August 22nd",2018-08-23 10:51:00-04:00,INGN,neutral
668208.0,"Stifel Nicolaus Reinstates Buy on Inogen, Announces $258",2018-08-22 07:10:00-04:00,INGN,neutral
668209.0,"Stocks Which Set New 52-Week High Yesterday, August 8th",2018-08-09 11:03:00-04:00,INGN,neutral
668210.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,INGN,positive
668211.0,85 Biggest Movers From Yesterday,2018-08-09 05:15:00-04:00,INGN,neutral
668212.0,68 Stocks Moving In Wednesday's Mid-Day Session,2018-08-08 12:30:00-04:00,INGN,neutral
668213.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,INGN,positive
668214.0,40 Stocks Moving In Wednesday's Pre-Market Session,2018-08-08 08:08:00-04:00,INGN,neutral
668215.0,Inogen shares are up 5.5% after the company beat beat Q2 earnings estimates and raised 2018 sales guidance.,2018-08-07 18:16:00-04:00,INGN,positive
668216.0,Inogen Raises FY18 Sales Guidance From $310M-$320M To $340M-$250M vs $323.11M Est.,2018-08-07 17:05:00-04:00,INGN,neutral
668217.0,"Inogen Q2 EPS $0.65 Beats $0.44 Estimate, Sales $97.238M Beat $81.98M Estimate",2018-08-07 16:25:00-04:00,INGN,neutral
668218.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,INGN,neutral
668219.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,INGN,negative
668220.0,"Inogen Shares Fall 1% As Traders Circulate Old Tweet From Citron; No New Information Is Out On Inogen; While Shares Have Rebounded, Stock Still Down 0.2% From When Circulation Began",2018-07-11 13:21:00-04:00,INGN,positive
668221.0,"Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate",2018-06-06 08:38:00-04:00,INGN,positive
668222.0,KeyBanc Initiates Coverage On Inogen with Sector Weight Rating,2018-06-06 06:10:00-04:00,INGN,neutral
668223.0,Inogen Hit By Citron Report; Analyst Rebuttal Calls This 'An Excellent Entry Point',2018-05-24 15:01:00-04:00,INGN,positive
668224.0,"Needham Out Defending Inogen, Says Short Report From Citron Has Created An Excellent Entry Point; Says Co.'s Growth Rate And Market Share Gians Indicate That Its R&D Spending Is Sufficient In Their View",2018-05-24 12:41:00-04:00,INGN,positive
668225.0,Citron's Andrew Left Talking Inogen On CNBC,2018-05-24 12:37:00-04:00,INGN,neutral
668226.0,'Andrew Left of Citron to be on CNBC at 12:30 EST with @ScottWapnerCNBC to discuss new report.'-Citron Research Tweet,2018-05-24 10:22:00-04:00,INGN,neutral
668227.0,"'Citron reports on $INGN tgt price $95. Our most compelling idea in med-tech in years.  $INGN most expensive name in med-tech / medical supplies with no pipeline, R&D in a highly competitive market.'-Citron Research Tweet",2018-05-24 10:20:00-04:00,INGN,positive
668228.0,"Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results",2018-05-10 09:44:00-04:00,INGN,neutral
668229.0,"Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings",2018-05-02 07:41:00-04:00,INGN,neutral
668230.0,42 Biggest Movers From Yesterday,2018-05-02 05:31:00-04:00,INGN,neutral
668231.0,Mid-Afternoon Market Update: NASDAQ Up 0.5%; Inogen Shares Spike Higher,2018-05-01 15:01:00-04:00,INGN,positive
668232.0,32 Stocks Moving In Tuesday's Mid-Day Session,2018-05-01 13:04:00-04:00,INGN,neutral
668233.0,Mid-Day Market Update: Crude Oil Down 1.8%;  Nutrisystem Shares Climb On Upbeat Earnings,2018-05-01 12:15:00-04:00,INGN,negative
668234.0,Mid-Morning Market Update: Markets Open Lower; Pfizer Posts Mixed Q1 Results,2018-05-01 10:38:00-04:00,INGN,negative
668235.0,"JP Morgan Maintains Overweight on Inogen, Raises Price Target to $180.00",2018-05-01 09:20:00-04:00,INGN,neutral
668236.0,21 Stocks Moving In Tuesday's Pre-Market Session,2018-05-01 08:32:00-04:00,INGN,neutral
668237.0,"Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings",2018-05-01 07:51:00-04:00,INGN,neutral
668238.0,Inogen Shares Up 18.8% After Hours Following Q1 Sales Beat And FY18 Sales Guidance Raise,2018-04-30 17:24:00-04:00,INGN,positive
668239.0,6 Stocks Moving In Monday's After-Hours Session,2018-04-30 17:03:00-04:00,INGN,neutral
668240.0,"UPDATE: Inogen Raises FY18 Sales Guidance From $298M-$308M To $310M-$320M vs $304.3M Est., Adj. Net Income From $36M-$39M To $38M-$41M, Adj. EBITDA From $60M-$64M To $62M-$67M",2018-04-30 16:14:00-04:00,INGN,neutral
668241.0,"Inogen Q1 EPS $0.48 vs $0.27 In Same Qtr. Last Year, Adj. EBITDA $15.5M vs $10.9M YoY, Sales $79.1M Beats $63.9M Est.; Raises Outlook",2018-04-30 16:13:00-04:00,INGN,neutral
668242.0,UPDATE: Inogen Says It Has Taken Steps To Prevent A Similar Incident From Occurring In The Future,2018-04-13 06:13:00-04:00,INGN,neutral
668243.0,"UPDATE: Inogen Says Co. Will Notify ~30K Current, Former Customers Of The Data Security Incident",2018-04-13 06:12:00-04:00,INGN,positive
668244.0,UPDATE: Inogen Says Messages Within An Employee Email Account Were Accessed By Unknown Persons Outside The Co. Without Authorization,2018-04-13 06:12:00-04:00,INGN,neutral
668245.0,Inogen 8-K Shows News Of A Data Security Incident; Co. Says Mgmt. 'Remains Confident' With Its FY18 Outlook,2018-04-13 06:11:00-04:00,INGN,positive
668246.0,"Inogen Reports Q4 Adj. Net Income $7M, EPS $(0.03) vs $0.25 In Same Qtr. Last Year, Sales $63.787M vs $61.8M Est.",2018-02-27 16:49:00-05:00,INGN,neutral
668247.0,PiperJaffray Upgrades Inogen to Overweight,2018-02-20 09:11:00-05:00,INGN,negative
668248.0,57 Biggest Movers From Yesterday,2017-11-09 05:16:00-05:00,INGN,neutral
668249.0,Inogen Shares Up 16.75% After Co. Tuesday Reported Q3 Results That Comfortably Exceeded Expectations,2017-11-08 15:05:00-05:00,INGN,positive
668250.0,46 Stocks Moving In Wednesday's Mid-Day Session,2017-11-08 12:31:00-05:00,INGN,neutral
668251.0,Inogen Raises FY17 Sales Guidance From $239M-$243M To $244M-$284M,2017-11-07 16:25:00-05:00,INGN,neutral
668252.0,"Inogen Reports Q3 EPS $0.33 vs. $0.29 Est., Sales $69M vs. $63.6M Est.",2017-11-07 16:24:00-05:00,INGN,neutral
668253.0,"Jim Cramer Weighs In On Teva, International Paper And Inogen",2017-08-16 06:51:00-04:00,INGN,neutral
668254.0,25 Stocks Moving In Monday's Pre-Market Session,2017-08-07 08:06:00-04:00,INGN,neutral
668255.0,"Inogen Increases FY17 Sales From $233-$239M to $239-$243M, Narrows Adj. EBITDA Guidance From $46-$50M To $48-$50M",2017-08-03 16:29:00-04:00,INGN,neutral
668256.0,"Inogen Reports Q2 EPS $0.38 vs $0.28 Est., Sales $64.12M vs $59.99M Est",2017-08-03 16:28:00-04:00,INGN,neutral
668313.0,"Cardiovascular Systems Innovation On Track, Competition Rife",2017-06-07 13:56:00-04:00,INGN,positive
668314.0,"Inogen Reports Q1 EPS $0.27 vs $0.12 In Same Qtr. Last Year, Sales $52.5M vs $120K Est.",2017-05-09 17:17:00-04:00,INGN,neutral
668315.0,"Inogen Reports Q4 Adj. EPS $0.26 vs $0.11, Sales $50.9M vs $46.52M Est.",2017-02-28 16:34:00-05:00,INGN,neutral
668316.0,Key Presenters At Leerink's Healthcare Conference,2017-02-13 15:52:00-05:00,INGN,neutral
668317.0,Inogen Names President and COO Scott Wilkinson as President and CEO,2016-12-06 06:11:00-05:00,INGN,neutral
668318.0,Inogen Names  Scott Wilkinson as President and CEO,2016-12-06 04:26:00-05:00,INGN,neutral
668319.0,Stifel Healthcare Conference Continues Today,2016-11-16 10:26:00-05:00,INGN,neutral
668320.0,Inogen Sees FY17 Rev. $230-$236M vs. Est. $192M,2016-11-03 17:22:00-04:00,INGN,neutral
668321.0,"Inongen Reports Q3 EPS $0.16 vs. Est. $0.13, Rev. $54.42M vs. Est. $47.89M",2016-11-03 17:21:00-04:00,INGN,neutral
668322.0,Stocks Hitting 52-Week Highs,2016-09-23 10:24:00-04:00,INGN,neutral
668323.0,Inogen Annoucnes Its Portable Oxygen Concentrator Now Allowed For Use Onboard Commercial Aircraft,2016-08-22 16:04:00-04:00,INGN,neutral
668324.0,Stifel Nicolaus Downgrades Inogen to Hold,2016-08-05 06:44:00-04:00,INGN,neutral
668325.0,Inogen Sees FY16 Rev. $190-$194M vs. Est. $189M,2016-08-04 17:02:00-04:00,INGN,neutral
668326.0,"Inogen Reports Q2 EPS $0.25 vs. Est. $0.20, Rev. $54.56M vs. Est. $52.4M",2016-08-04 17:01:00-04:00,INGN,neutral
668327.0,JP Morgan Initiates Coverage on Inogen at Overweight,2016-07-13 09:07:00-04:00,INGN,neutral
668328.0,Inogen Sees FY 2016 Revenue $187M to $191M vs $189.19M est,2016-05-09 17:24:00-04:00,INGN,neutral
668329.0,"UPDATE: Inogen Reaffirms FY16 Sales $187M-$191M vs $190M Est., Adj. EBITDA $37M-$39M",2016-05-09 17:23:00-04:00,INGN,neutral
668330.0,"Inogen Q1 EPS $0.11 vs $0.12 est, Revenue $42.99M vs $41.75M est",2016-05-09 17:23:00-04:00,INGN,neutral
668331.0,Inogen Reaffirms FY16 Outlook,2016-05-09 17:23:00-04:00,INGN,neutral
668332.0,"Inogen Reports Q1 EPS $0.11 vs $0.12 Est., Sales $43M v s$41.8M Est.",2016-05-09 17:22:00-04:00,INGN,neutral
668333.0,Benzinga's Top Initiations,2016-03-24 09:38:00-04:00,INGN,positive
668334.0,Piper Jaffray Initiates Coverage on Inogen at Neutral,2016-03-24 06:15:00-04:00,INGN,neutral
668335.0,Mid-Afternoon Market Update: Celator Pharmaceuticals Surges On Phase 3 Trial Results For Vyxeos; Constellium Shares Slide,2016-03-15 14:46:00-04:00,INGN,positive
668336.0,Mid-Day Market Update: Inogen Jumps On Upbeat Results; Foresight Energy Shares Decline,2016-03-15 12:03:00-04:00,INGN,positive
668337.0,Benzinga's Volume Movers,2016-03-15 10:20:00-04:00,INGN,neutral
668338.0,"UPDATE: Inogen Raises FY16 Sales Outlook from $177M-$183M to $187M-$191M, Adj. EBITDA from $35M-$37M to $37M-$39M, Adj. Net Income $12M-$14M",2016-03-14 16:03:00-04:00,INGN,neutral
668339.0,Inogen Raises FY16 Outlook,2016-03-14 16:03:00-04:00,INGN,neutral
668340.0,"Inogen Reports Q4 EPS $0.19 vs $0.07 in Same Qtr. Last Year, Sales $40.446M vs $29.1M YoY",2016-03-14 16:02:00-04:00,INGN,neutral
668341.0,Inogen Sees FY Revenue $177M to $183M vs $181M est,2015-11-30 07:01:00-05:00,INGN,neutral
668342.0,"Inogen Reports Q3 EPS $0.13, Sales $40.8M; Sees FY Rev $150M-$153M",2015-11-10 16:07:00-05:00,INGN,neutral
668343.0,Stocks Hitting 52-Week Highs,2015-09-14 10:05:00-04:00,INGN,neutral
668344.0,Mid-Afternoon Market Update: Freshpet Slides On Earnings Miss; Inogen Shares Spike Higher,2015-08-12 15:28:00-04:00,INGN,positive
668345.0,"Mid-Day Market Update: Wednesday's Movers, China Intervenes With Yuan And Kraft Heinz Job Cut",2015-08-12 12:17:00-04:00,INGN,negative
668346.0,Stocks Hitting 52-Week Highs,2015-08-12 10:16:00-04:00,INGN,neutral
668347.0,"Inogen Reports Q2 EPS $0.17, Sales 44.029M, no estimates",2015-08-11 16:08:00-04:00,INGN,negative
668348.0,Benzinga's Volume Movers,2015-06-16 10:23:00-04:00,INGN,neutral
668349.0,"Inogen Reports Q1 EPS $0.08, Rev. $33.752M",2015-05-12 16:06:00-04:00,INGN,neutral
668350.0,"Inogen Q4 EPS $0.07, Revenue $29.1M, No Estimates",2015-04-27 06:30:00-04:00,INGN,negative
668351.0,Inogen Given Expected NASDAQ Notice Of Non-Compliance,2015-04-20 16:02:00-04:00,INGN,neutral
668352.0,Analyst Says Inogen Won't Restate Prior Results,2015-04-16 16:23:00-04:00,INGN,neutral
668353.0,Needham Assumes Inogen at Strong Buy,2015-04-16 07:41:00-04:00,INGN,positive
668354.0,"Inogen Announces Delay of Form 10-K Filing, Cites Discovery of Some Potential Accounting Matters; Expecting to Meet or Exceed FY14 Outlook, Reaffirms FY15 Guidance",2015-04-14 17:15:00-04:00,INGN,negative
668355.0,"Inogen Announces Will File Form 12b-25 with SEC, Says Did Not File by Deadline Amid Internal Probe Related to Potential Violation of Accounting Policies",2015-03-31 17:05:00-04:00,INGN,negative
668356.0,Morning Market Losers,2015-03-12 09:56:00-04:00,INGN,negative
668357.0,Benzinga's Top #PreMarket Losers,2015-03-12 08:20:00-04:00,INGN,negative
668358.0,Stocks Hitting 52-Week Highs,2015-03-11 10:04:00-04:00,INGN,neutral
668359.0,Stifel Nicolaus Upgrades Inogen To  Buy,2015-03-11 08:54:00-04:00,INGN,neutral
668360.0,Benzinga's Top Upgrades,2015-03-11 08:36:00-04:00,INGN,positive
668361.0,"Stifel Nicolaus Upgrades Inogen to Buy, Announces $45.00 PT",2015-03-11 06:20:00-04:00,INGN,neutral
668362.0,Stifel Nicolaus Upgrades Inogen to Buy,2015-03-11 05:02:00-04:00,INGN,neutral
668363.0,From 13d Inogen Holder Nova A/S Reports 19.1% Down 19.05% In November 2014,2015-02-02 10:43:00-05:00,INGN,neutral
668364.0,Inogen Announces Reimbursement Of The Inogen One G3 In Germany,2014-12-23 08:06:00-05:00,INGN,neutral
668365.0,Stocks Hitting 52-Week Highs,2014-12-22 10:31:00-05:00,INGN,neutral
668366.0,Inogen Sees FY2015 Sales $130.0M-135.0M vs $133.20M Est,2014-12-15 06:09:00-05:00,INGN,neutral
668367.0,"Inogen Director Rider Buys 3,000 Shares @$25.00/Share -Form 4",2014-11-17 13:10:00-05:00,INGN,positive
668368.0,Inogen Raises FY2014 Sales Guidance from $102.0M-106.0M to $106.0M-110.0M vs $106.70M Est; Sees FY2015 Sales $130.0M-135.0M vs $127.0M Est,2014-11-11 16:29:00-05:00,INGN,neutral
668369.0,Inogen Reports Q3 EPS of $0.11 vs $0.06 Est; Revenue of $29.40M vs $26.49M Est,2014-11-11 16:07:00-05:00,INGN,neutral
668370.0,"Earnings Scheduled For November 11, 2014",2014-11-11 04:56:00-05:00,INGN,neutral
668371.0,Inogen Selects JPMorgan Chase & Co. For Primary Banking Relationship,2014-11-10 16:08:00-05:00,INGN,neutral
668372.0,Benzinga's Volume Movers,2014-11-10 10:28:00-05:00,INGN,neutral
668373.0,"Needham Initiates Coverage on Inogen at Strong Buy, Announces $32.00 PT",2014-11-10 06:05:00-05:00,INGN,positive
668374.0,Benzinga's Top #PreMarket Losers,2014-10-30 08:27:00-04:00,INGN,negative
668375.0,Inogen Prices 2.1M Share Offering @$21.50/Share,2014-10-29 20:47:00-04:00,INGN,positive
668376.0,Inogen Reports Prelim. Q3 Sales At Least $28.0M vs $26.60M Est,2014-10-27 16:23:00-04:00,INGN,neutral
668377.0,Inogen Announces Launch of 2.1M Share Proposed Secondary Public Offering by Selling Stockholders ,2014-10-27 16:09:00-04:00,INGN,positive
668378.0,Inogen Announces Release to Market of the Inogen At Home (TM),2014-10-21 08:13:00-04:00,INGN,neutral
668379.0,Inogen Announces Reimbursement for Inogen One G3 in France,2014-09-09 09:02:00-04:00,INGN,neutral
668380.0,Inogen Earnings Press Release Included Comment on Receiving 510(k) Clearance for Inogen at Home,2014-08-12 16:17:00-04:00,INGN,neutral
668381.0,Inogen Sees FY2014 Sales $102.0M-106.0M vs $95.80M Est,2014-08-12 16:16:00-04:00,INGN,neutral
668382.0,Inogen Reports Q2 EPS of $0.11 vs $0.07 Est; Revenue of $30.40M vs $23.93M Est,2014-08-12 16:11:00-04:00,INGN,neutral
668383.0,Inogen Reports FDA Clearance of Home Oxygen Concentrator,2014-06-24 09:03:00-04:00,INGN,neutral
668384.0,Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th,2014-06-10 11:04:00-04:00,INGN,neutral
668385.0,Inogen Raises FY2014 Sales Guidance from $90.0M-94.0M to $92.0M-96.0M vs $91.68M Est,2014-05-13 16:28:00-04:00,INGN,neutral
668386.0,Inogen Reports Q1 EPS of $0.05 vs $0.04 Est; Revenue of $23.60M vs $20.69M Est; Raises FY14 Outlook,2014-05-13 16:09:00-04:00,INGN,neutral
668387.0,Inogen Sees FY2014 Sales $90.0M-94.0M vs $90.90M Est,2014-03-27 16:04:00-04:00,INGN,neutral
668388.0,"Earnings Scheduled For March 27, 2014",2014-03-27 05:03:00-04:00,INGN,neutral
668389.0,William Blair Initiates Coverage on Inogen at Outperform,2014-03-11 11:00:00-04:00,INGN,neutral
668390.0,"Leerink Partners Initiates Coverage on Inogen at Outperform, Announces $26.00 PT",2014-03-11 08:52:00-04:00,INGN,neutral
668391.0,Benzinga's Top Initiations,2014-03-11 08:37:00-04:00,INGN,positive
668392.0,Stifel Nicolaus Initiates Coverage on Inogen at Hold,2014-03-11 07:09:00-04:00,INGN,neutral
668393.0,"Inogen Shares Open for Trade at $16/Share, Priced at $16",2014-02-14 10:26:00-05:00,INGN,positive
668394.0,"Inogen IPO to Open for Quote at 10:10AM EST, Expected to Open for Trade at 10:25AM EST; Priced 4.4M Shares at $16/Share",2014-02-14 09:51:00-05:00,INGN,positive
